@StanfordMed: https://x.com/StanfordMed/status/2080452706385416506
Summary
Researchers are exploring agentic AI as co-scientists that can independently assist with ideation, hypothesis generation, and accelerating scientific exploration in biomedical research.
View Cached Full Text
Cached at: 07/24/26, 11:09 AM
Agentic AI in biomedical research: What is it and can it expedite science?
https://stan.md/4wX4Yk6
Researchers are venturing into a new area of collaboration that relies on agentic AI, co-scientists that can act independently and help humans ideate, hypothesize and speed up scientific exploration.
Similar Articles
Teams of AI agents boost speed of research
AI systems using teams of agents, like Google's Co-Scientist and FutureHouse's Robin, can accelerate drug repurposing research by developing hypotheses, proposing experiments, and analyzing data in hours instead of months.
@EricTopol: Just published @ScienceMagazine Impressively broad range of life science research getting done autonomously with agenti…
A paper published in Science Magazine demonstrates a broad range of life science research being conducted autonomously using agentic AI to accelerate discovery.
Two AI-based science assistants succeed with drug-retargeting tasks
Two AI-powered science assistants, Google's Co-Scientist and FutureHouse's Robin, can generate hypotheses and analyze biological data for drug retargeting, helping researchers find non-obvious connections across scientific fields.
Scientific computing in the age of agentic AI
OpenAI shares a field report on using AI agents like Codex and Claude Code to assist in scientific computing projects, showing significant acceleration in software development and maintenance while shifting researchers' roles to verification and orchestration.
@GoogleDeepMind: From proposing hypotheses to designing experiments, AI agents are starting to reshape scientific discovery. But the har…
Google DeepMind's essay explores how AI agents are transforming scientific discovery by generating hypotheses and designing experiments, while highlighting a growing validation bottleneck and proposing priorities for policymakers and funders.